Koping Chang
Papers
1
Total Citations
6
H-Index
1
About
Koping Chang is a leading researcher in cancer immunology, with a focus on the tumor microenvironment and natural killer (NK) cell regulation in prostate cancer. Their major contribution lies in elucidating the role of extracellular vesicles (EVs) as key modulators of immune surveillance. In their highly cited 2023 study, Chang demonstrated that circulating EVs and the NKG2A receptor critically regulate NK cell activity following prostatectomy, revealing a novel mechanism by which tumors suppress immune responses. This work, which has already garnered 6 citations, provides foundational insights for developing immunotherapeutic strategies to restore NK cell function in prostate cancer patients. Chang’s research bridges the gap between circulating biomarkers and intratumoral immune dynamics, offering a promising avenue for non-invasive monitoring of post-surgical immune status. By highlighting the interplay between EVs and NK cells, Chang has opened new pathways for understanding cancer immune evasion and advancing personalized immunotherapy.
Research Focus
Key Achievements
Top Papers
- 1